secwatch / observer
8-K filed May 9, 2023, 7:59 PM ET ticker ASRT CIK 0001808665
earnings confidence high sentiment positive materiality 0.80

Assertio Q1 sales +18% to $41.8M; raises FY2023 outlook; plans Spectrum acquisition in Q3

Assertio Holdings, Inc.

2023-Q1 EPS reported -$0.07 revenue$42,466,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Assertio Holdings, Inc. reported the three months ended March 31, 2023 results: revenue $41.8 million, net income $(3.5) million, EPS $(0.07) per share. Guidance raised.

Period
the three months ended March 31, 2023
Revenue
$41.8 million
Net income
$(3.5) million
EPS
$(0.07) per share
Guidance
raised
Result
reported results
Exact text from the filing
Adjusted Earnings Per Share (Non-GAAP) 1 $ 0.29 $ 0.38 First quarter results included the following as compared to the prior year quarter: • Net product sales increased 18%, to $41.8 million. ◦ Increased sales of Indocin and the addition of Sympazan more than offset expected declines in Cambia and Zipsor. ◦ Indocin sales increased 42%, primarily due to the transition
View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Assertio Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001808665-23-000028
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.